SEER
Companies
NASDAQ
Seer Inc.
Health Care
$2.00
-$0.31 (-13.42%)
Price Chart
Overview
About SEER
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
Market Cap
$112.3M
Volume
490.3K
Avg. Volume
477.6K
P/E Ratio
-1.3441558
Dividend Yield
0.00%
Employees
152.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.80
Moderate Correlation
Volatility
High (0.47)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, SEER shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$112.3M
Volume490.3K
P/E Ratio-1.34
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025